Established in 2014, NapiFeryn BioTech aims to improve life quality by using technology to produce natural and functional plant derived proteins.
Supported by EIT Food
NapiFeryn extracts protein from rapeseed oil production waste streams, providing a sustainable alternative to animal-derived proteins. NapiFeryn’s technology extracts food-grade protein from rapeseed cake so that it can be a viable alternative to both meat- and soy-based proteins. The system is able to extract, purify and isolate the proteins in the oilseed for use in food and the protein is as nutritional as plant-based market leader soy, creating a product that is more sustainable and affordable for consumers.
NapiFeryn BioTech (NFB in short), is a combination of two names of proteins that are obtained from rapeseed: napin and cruciferin. The company is located in Łódź, at Bionanopark – a science and technology park and it has a lab equipped with devices for testing the production process at a laboratory scale.
The company is still in the pre-commercialisation phase, and will need all of those partners to work together to ensure the technology makes it out of the lab and delivers on its clear potential.
EIT Community support
Piotr Wnukowski, co-founder of NapiFeryn, was nominated for the EIT Venture Award in 2019.
NapiFeryn BioTech is one of the partners of the EIT Food RIS Fellowships, the programme dedicated to MSc students, graduates and young entrepreneurs. The company is involved in a series of other EIT Food projects.
EIT Food supports partners in one year impactful innovation project close to the market, where they can work together. We have been invited to two innovation projects so far and they’re a great opportunity to work with partners from across the European Union.
Magdalena Kozlowska, CEO of NapiFeryn
Want to know more about NapiFeryn?
This project was awarded funding from the EIT’s Crisis Response Initiative and this solution directly contributes to the European Union's response to the COVID-19 pandemic.